000 | 00829 a2200229 4500 | ||
---|---|---|---|
005 | 20250515224124.0 | ||
264 | 0 | _c20101004 | |
008 | 201010s 0 0 spa d | ||
022 | _a1578-2190 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDaudén, E | |
245 | 0 | 0 |
_a[Chemical structure of etanercept, pharmacokinetics and mechanism of action]. _h[electronic resource] |
260 |
_bActas dermo-sifiliograficas _cMay 2010 |
||
300 |
_a1-4 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Introductory Journal Article | ||
650 | 0 | 4 | _aEtanercept |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xchemistry |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xchemistry |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
773 | 0 |
_tActas dermo-sifiliograficas _gvol. 101 Suppl 1 _gp. 1-4 |
|
999 |
_c19845990 _d19845990 |